Bath & Body Works has seen its fair value estimate trimmed modestly, moving from $38.83 to $37.77 per share as analysts absorb the latest developments. This adjustment reflects a nuanced view that tempers optimism about recent business stabilization while also noting continuing concerns about sales momentum and margin pressure. Investors will want to keep a close eye on these shifts to stay informed about the evolving story of Bath & Body Works stock.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Bath & Body Works.

Analyst coverage of Bath & Body Works reflects a mix of cautious optimism and lingering concerns. The following highlights summarize recent commentary from the sell side:

???? Bullish Takeaways

Morgan Stanley's Alex Straton maintained an Overweight rating on Bath & Body Works, adjusting the price target only slightly to $40 from $41 following updated estimates after Q2 results. This signals continued confidence in the company's ability to deliver value, despite near-term adjustments.

Barclays analyst Adrienne Yih increased the firm’s price target to $32 from $30 and reiterated an Equal Weight rating in response to the fiscal Q2 report. Yih pointed to tariff impacts being most significant in Q3 and took a constructive stance on the company’s ability to manage through these challenges.

???? Bearish Takeaways

Jefferies reduced its price target to $28.50 from $32 and maintained a Hold rating, expressing concern over sustained promotional activity and the limited impact of new product launches. The firm noted that, despite CEO Daniel Heaf's strategy to reduce reliance on sales and promotions, rapid discounting continues to pressure margins and sales growth.

Broader macroeconomic uncertainty and the inconsistent performance of new product rollouts contribute to a cautious outlook, especially regarding near-term upside for sales and margins.

Overall, while some analysts highlight solid execution and resilience in navigating current headwinds, others flag persistent risks tied to promotional intensity, margin pressure, and external factors. These insights have contributed to recent modest trims in valuation targets and a generally balanced, if cautious, sentiment toward Bath & Body Works stock.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

Bath & Body Works revised its outlook for full-year 2025, now expecting net sales growth between 1.5% and 2.7% compared to $7,307 million in fiscal 2024. The company forecasts third-quarter 2025 sales will increase by 1% to 3%, though earnings per share are projected to be lower year over year.

The company completed a major share repurchase program, buying back over 8 million shares, representing 3.74% of its outstanding stock, for a total of $238.71 million. This buyback was part of an initiative announced earlier in 2025.

Bath & Body Works launched The Disney Villains Collection, inspired by Maleficent and the Evil Queen. The new line, featuring themed fragrances and products, is available both domestically and internationally beginning September 3, 2025. Loyalty members gain exclusive early access starting August 26.

The Fair Value Estimate has declined modestly, decreasing from $38.83 to $37.77 per share.

The Discount Rate has risen slightly, moving from 10.63% to 10.70%.

Revenue Growth expectations edged lower, changing from 3.00% to 2.95% annually.

The Net Profit Margin is nearly unchanged, ticking up marginally from 10.40% to 10.41%.

The Future P/E Ratio forecast has fallen, now at 10.83x compared to the previous estimate of 11.11x.

A Narrative is a dynamic story built around a company's strategy, numbers, and future expectations. On Simply Wall St, millions of investors use Narratives to bring a personal perspective to fair value estimates and forecasts. Narratives connect the company’s journey with real financial data. They help you decide when to buy or sell by comparing Fair Value to the current Price and are updated instantly when fresh news or results emerge. You’ll find them easily in our Community page.

Discover the original Bath & Body Works Narrative and follow along to keep your investing decisions a step ahead:

See how brand investments, digital innovation, and global expansion are expected to drive long-term growth and higher customer retention

Stay on top of key risks like digital underperformance, tariff pressures, and heavy promotions that could threaten future margins and sustained growth

Get real-time updates on new analyst forecasts, price targets, and how these changing factors impact the fair value and buy/sell signals on Bath & Body Works

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BBWI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com